Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital

被引:47
|
作者
O'Sullivan, JM
Norman, AR
Cook, GJ
Fisher, C
Dearnaley, DP
机构
[1] Royal Marsden Hosp, Royal Marsden NHS Trust, Inst Canc Res, Acad Unit Radiotherapy & Clin Oncol, Sutton SM2 5PT, Surrey, England
[2] Royal Marsden Hosp, Inst Canc Res, Dept Comp & Informat, Sutton SM2 5PT, Surrey, England
[3] Royal Marsden Hosp, Inst Canc Res, Dept Nucl Med, Sutton SM2 5PT, Surrey, England
[4] Royal Marsden Hosp, Inst Canc Res, Dept Histopathol, Sutton SM2 5PT, Surrey, England
关键词
radionuclide imaging; prostatic neoplasms; bone metastases; Gleason scoring;
D O I
10.1046/j.1464-410X.2003.04480.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To determine if it is possible to exclude staging bone scans in a greater proportion of patients if more consideration is given to T stage and Gleason score, as recent guidelines from the National Institute of Clinical Excellence state that routine staging bone scans for prostate cancer are unnecessary in patients with a prostate specific antigen level (PSA) of < 10 ng/mL and Gleason scores of < 8. We identified a cohort of consecutive patients with untreated prostate cancer who had a staging isotope bone scan between 1 January 1995 and 31 December 2000, who were not on hormone therapy, who had their PSA estimated within 30 days of the scan, and who had histologically confirmed prostate cancer on biopsy reviewed at the Royal Marsden. Data were analysed according to Gleason score, major Gleason grade, clinical T-stage and PSA level. In all, 420 patients were identified who fulfilled the criteria for inclusion; 67 scans (16%, 95% confidence interval, CI, 13-20%) were positive. Of the 187 scans taken in patients with a PSA level of less than or equal to 20 ng/mL, stage < T4 and Gleason < 8 (with major Gleason grade < 4), two (1%, 0.3-4%) were reported as positive, giving a negative predictive value of 99% (95% CI 98.5-99.5%) for these criteria for avoiding the need for staging bone scans. In 116 patients (28%) with Gleason score 7, of whom 28 (24%) had positive scans, there was a statistically significant association between positive scans and a major Gleason pattern of 4 compared with 3. Isotope bone scans are an unnecessary part of staging of prostate cancer if the PSA level is less than or equal to 20 ng/mL, stage < T4 and Gleason score < 8, and should be omitted unless the major Gleason pattern is 4. The present results suggest that by considering the Gleason score and T stage, a larger proportion of patients with prostate cancer than previously thought could avoid a staging bone scan.
引用
收藏
页码:685 / 689
页数:5
相关论文
共 50 条
  • [41] A retrospective study from the Royal Marsden Hospital (RMH) of patients with malignant perivascular epithelioid cell tumors (PEComa) receiving treatment with sirolimus (SI) or temsirolimus (TSI)
    Pedersen, Joanna Vitfell
    Benson, Charlotte
    Tunariu, Nina
    Mitchell, Scott
    Fisher, Cyril
    Thway, Khin
    Larkin, James M. G.
    Scurr, Michelle
    Judson, Ian Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Inflammatory Breast Cancer-The Royal Marsden Hospital Experience A Review of 155 Patients Treated From 1990 to 2007
    Sutherland, Stephanie
    Ashley, Sue
    Walsh, Geraldine
    Smith, Ian E.
    Johnston, Stephen R. D.
    CANCER, 2010, 116 (11) : 2815 - 2820
  • [43] Staging Patients with Prostate Cancer - Who Should Have an Isotope Bone Scan?
    Rose, N.
    Kurban, L.
    Wardlaw, K.
    SCOTTISH MEDICAL JOURNAL, 2010, 55 (01) : 50 - 50
  • [44] Retrospective study of the utility of 18F sodium fluoride PET bone scans in patients with thyroid cancer
    Schneider, Mark
    Garcia, Carlos
    O'Neil, Jeffrey
    Van Nostrand, Douglas
    Wexler, Jason
    Burman, Kenneth
    Wartofsky, Leonard
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [45] Progression of Disease in Bone in Patients with Prostate Cancer - an Automated Serial Analysis of Whole Body Bone Scans
    Kaboteh, R.
    Jonsson, E.
    Sjostrand, K.
    Gjertsson, P.
    Edenbrandt, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S143 - S143
  • [46] Effect of statins use on mortality of prostate cancer patients in a Singapore tertiary hospital - a retrospective study
    Oo, M. M.
    Sun, B.
    Tan, T. W.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 107 - 107
  • [47] ASSESSMENT OF VALUE OF ROUTINE BONE SCANS IN PATIENTS WITH NEWLY DIAGNOSED PROSTATE-CANCER
    GERBER, G
    CHODAK, GW
    UROLOGY, 1991, 37 (05) : 418 - 422
  • [48] CORRELATION OF BONE SCANS AND SERUM PSA LEVELS IN TREATED PATIENTS WITH PROSTATE-CANCER
    ACEVEDO, ME
    GRACIA, S
    SILVA, F
    BORDEWYK, RP
    ORDUNA, E
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P32 - P33
  • [49] Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan
    Kosuda, S
    Yoshimura, I
    Aizawa, T
    Koizumi, K
    Akakura, K
    Kuyama, J
    Ichihara, K
    Yonese, J
    Koizumi, M
    Nakashima, J
    Fujii, H
    CANCER, 2002, 94 (04) : 964 - 972
  • [50] A narrowing range of bone scan in newly diagnosed prostate cancer patients: A retrospective comparative study
    Ozgur, Berat Cem
    Gultekin, Sinan
    Ekici, Musa
    Yilmazer, Demet
    Alper, Murat
    UROLOGY ANNALS, 2015, 7 (02) : 193 - 198